Home » AVALON PHARMACEUTICALS ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING
AVALON PHARMACEUTICALS ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING
Avalon Pharmaceuticals, Inc. today announced the pricing of its initial public offering of 2,750,000 shares of its common stock at a price to the public of $10.50 per share. All of the shares are being offered by Avalon. In addition, Avalon has granted to the underwriters a 30-day option to purchase up to an additional 412,500 shares to cover over-allotments, if any.
PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/09-29-2005/0004134595&EDATE=)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May